A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage

Hiroshi Tanaka, Hirofumi Arakawa, Tatsuya Yamaguchi, Kenji Shiraishi, Seisuke Fukuda, Kuniko Matsui, Yoshiki Takei and Yusuke Nakamura ()
Additional contact information
Hiroshi Tanaka: Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo
Hirofumi Arakawa: Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo
Tatsuya Yamaguchi: Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo
Kenji Shiraishi: Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo
Seisuke Fukuda: Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo
Kuniko Matsui: Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo
Yoshiki Takei: Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo
Yusuke Nakamura: Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo

Nature, 2000, vol. 404, issue 6773, 42-49

Abstract: Abstract The p53 gene is frequently inactivated in human cancers. Here we have isolated a p53-inducible gene, p53R2, by using differential display to examine messenger RNAs in a cancer-derived human cell line carrying a highly regulated wild-type p53 expression system. p53R2 contains a p53-binding sequence in intron 1 and encodes a 351-amino-acid peptide with striking similarity to the ribonucleotide reductase small subunit (R2), which is important in DNA synthesis during cell division. Expression of p53R2, but not R2, was induced by ultraviolet and γ-irradiation and adriamycin treatment in a wild-type p53-dependent manner. Induction of p53R2 in p53-deficient cells caused G2/M arrest and prevented cells from death in response to adriamycin. Inhibition of endogenous p53R2 expression in cells that have an intact p53-dependent DNA damage checkpoint reduced ribonucleotide reductase activity, DNA repair and cell survival after exposure to various genotoxins. Our results indicate that p53R2 encodes a ribonucleotide reductase that is directly involved in the p53 checkpoint for repair of damaged DNA. The discovery of p53R2 clarifies a relationship between a ribonucleotide reductase activity involved in repair of damaged DNA and tumour suppression by p53.

Date: 2000
References: Add references at CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
https://www.nature.com/articles/35003506 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:404:y:2000:i:6773:d:10.1038_35003506

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/35003506

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().